Proinflammatory cytokines regulate tissue inhibitors of metalloproteinases and disintegrin metalloproteinase in cardiac cells

Cardiovascular Research

Volumn 42, Issue 1, 1999, Pages 162-172

  Li, Yun You ^a   McTiernan, Charles F ^a   Feldman, Arthur M ^a  

^a U   (United States)

Author keywords

Cytokines; Extracellular matrix; Gene expression; Metalloproteinases; Myocytes

Indexed keywords

DISINTEGRIN; INTERLEUKIN 1BETA; TISSUE INHIBITOR OF METALLOPROTEINASE;

ANIMAL EXPERIMENT; ARTICLE; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME REGULATION; EXTRACELLULAR MATRIX; GENE SEQUENCE; HEART FAILURE; HEART MUSCLE CELL; IMMUNOBLOTTING; IMMUNOREGULATION; NONHUMAN; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; RAT; REGENERATION;

ANIMALS; BLOTTING, NORTHERN; CELLS, CULTURED; CYTOKINES; DISINTEGRINS; ENZYME INHIBITORS; EXTRACELLULAR MATRIX; GENE EXPRESSION; HEART FAILURE, CONGESTIVE; INTERLEUKIN-1; METALLOENDOPEPTIDASES; MYOCARDIUM; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASE-3; TISSUE INHIBITOR OF METALLOPROTEINASES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0000393540     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(98)00297-1     Document Type: Article

References (38)

1. Tyagi S.C. Proteinases and myocardial extracellular matrix turnover. Mol Cell Biochem. 168:1997;1-12.
2. Cleutjens JP, Kandala JC, Guarda E, Guntaka RV, Weber KT Regulation of collagen degradation in the rat myocardium after infarction. J Mol Cell Cardiol. 27:1995;1281-1292.
3. Janicki JS, Brower GL, Henegar JR, Wang L Ventricular remodeling in heart failure: the role of myocardial collagen. Adv Exp Med Biol. 382:1995;239-245.
4. Gunja-Smith Z, Morales AR, Romanelli R, Woessner JF Jr. Remodeling of human myocardial collagen in idiopathic dilated cardiomyopathy. Role of metalloproteinases and pyridinoline cross-links. Am J Pathol. 148:1996;1639-1648.
5. Armstrong PW, Moe GW, Howard RJ, Grima EA, Cruz TF Structural remodelling in heart failure: gelatinase induction. Can J Cardiol. 10:1994;214-220.
6. Spinale FG, Coker ML, Thomas CVet al. Time-dependent changes in matrix metalloproteinase activity and expression during the progression of congestive heart failure. Circ Res. 82:1998;482-495.
7. Okada A, Garnier JM, Vicaire S, Basset P Cloning of the cDNA encoding rat tissue inhibitor of metalloproteinase 1 (TIMP-1), amino acid comparison with other TIMPs, and gene expression in rat tissues. Gene. 147:1994;301-302.
8. Cook TF, Burke JS, Bergman KDet al. Cloning and regulation of rat tissue inhibitor of metalloproteinases-2 in osteoblastic cells. Arch Biochem Biophys. 311:1994;313-320.
9. Silbiger SM, Jacobsen VL, Cupples RL, Koski RA Cloning of cDNAs encoding human TIMP-3, a novel member of the tissue inhibitor of metalloproteinase family. Gene. 141:1994;293-297.
10. Greene J, Wang M, Liu YEet al. Molecular cloning and characterization of human tissue inhibitor of metalloproteinase 4. J Biol Chem. 271:1996;30375-30380.
11. Leco KJ, Apte SS, Taniguchi GTet al. Murine tissue inhibitor of metalloproteinases-4 (TIMP-4): cDNA isolation and expression in adult mouse tissues. FEBS Lett. 401:1997;213-217.
12. Wolfsberg TG, Primakoff P, Myles DG, White JM ADAM, a novel family of membrane proteins containing a disintegrin and metalloprotease domain: multipotential functions in cell-cell and cell-matrix interactions. J Cell Biol. 131:1995;275-278.
13. Wolfsberg TG, Straight PD, Gerena RLet al. ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with a disintegrin and metalloprotease domain. Dev Biol. 169:1995;378-383.
14. Lunn CA, Fan X, Dalie Bet al. Purification of ADAM 10 from bovine spleen as a TNFα convertase. FEBS Lett. 400:1997;333-335.
15. Moss ML, Jin SL, Milla MEet al. Cloning of a disintegrin metalloproteinase that processes precursor tumour-necrosis factor-alpha. Nature. 385:1997;733-736.
16. Black RA, Rauch CT, Kozlosky CJet al. A metalloproteinase disintegrin that releases tumour- necrosis factor-alpha from cells. Nature. 385:1997;729-733.
17. Rosendahl MS, Ko SC, Long DLet al. Identification and characterization of a pro-tumor necrosis factor-alpha-processing enzyme from the ADAM family of zinc metalloproteases. J Biol Chem. 272:1997;24588-24593.
18. Li Y.Y., Feldman A.M., Sun Y., McTiernan C.F. Differential expression of tissue inhibitors of metalloproteinases in the failing human heart. Circulation. 98:1998;1728-1734.
19. Kubota T, McTiernan CF, Frye CSet al. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res. 81:1997;627-635.
20. Li YY, McTiernan CF, Feldman AM IL-1β alters the expression of the receptor tyrosine kinase gene r-EphA3 in neonatal rat cardiomyocytes. Am J Physiol. 274:1998;H331-H341.
21. McTiernan CF, Lemster BH, Frye Cet al. Interleukin-1β inhibits phospholamban gene expression in cultured cardiomyocytes. Circ Res. 81:1997;493-503.
22. Chomczynski P, Sacchi N Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
23. Howard L, Glynn P Membrane-associated metalloproteinase recognized by characteristic cleavage of myelin basic protein: assay and isolation. Methods Enzymol. 248:1995;388-395.
24. Bian J, Wang Y, Smith MRet al. Suppression of in vivo tumor growth and induction of suspension cell death by tissue inhibitor of metalloproteinases (TIMP)-3. Carcinogenesis. 17:1996;1805-1811.
25. Tyagi SC, Matsubara L, Weber KT Direct extraction and estimation of collagenase(s) activity by zymography in microquantities of rat myocardium and uterus. Clin Biochem. 26:1993;191-198.
26. Dunsmore SE, Rannels DE Turnover of extracellular matrix by type II pulmonary epithelial cells. Am J Physiol. 268:1995;L336-46.
27. Gerber SB, Voelkl KE, Anderson TW, Finn JD. SPSS: Guide to the New Statistical Analysis of Data. New York: Springer; 1997.
28. Zafarullah M, Su S, Martel-Pelletier Jet al. Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA is constitutively expressed in bovine, human normal, and osteoarthritic articular chondrocytes. J Cell Biochem. 60:1996;211-217.
29. Levine B, Kalman J, Mayer L, Fillit HM, Packer M Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. New Engl J Med. 323:1990;236-241.
30. Torre-Amione G, Kapadia S, Benedict Cet al. Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: a report from the studies of left ventricular dysfunction (SOLVD). J Am Coll Cardiol. 27:1996;1201-1206.
31. Testa M, Yeh M, Lee Pet al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol. 28:1996;964-971.
32. Torre-Amione G, Kapadia S, Lee Jet al. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart. Circulation. 93:1996;704-711.
33. Spinale FG, Krombach RS, Coker MLet al. Matrix metalloproteinase inhibition with congestive heart failure improves left ventricular geometry and pump function (Abstract). Circulation. 96:1997;I-520.
34. Peterson JT, Rosebury WS, Robertson AWet al. Matrix metalloproteinase inhibition blocks progression of heart failure (Abstract). Circulation. 96:1997;I-520.
35. Lew WYW, Lee M, Yasuda S, Bayna E Depyrogenation of digestive enzymes reduces lipopolysaccharide tolerance in isolated cardiac myocytes. J Mol Cell Cardiol. 29:1997;1985-1990.
36. Wagner DR, McTiernan CF, Sanders VJ, Feldman AM Adenosine inhibits lipopolysaccharide- induced secretion of tumor necrosis factor-α in the failing human heart. Circulation. 97:1998;521-524.
37. Pagani FD, Baker LS, Hsi Cet al. Left ventricular systolic and diastolic dysfunction after infusion of tumor necrosis factor-alpha in conscious dogs. J Clin Invest. 90:1992;389-398.
38. Krown KA, Page MT, Nguyen Cet al. Tumor necrosis factor alpha-induced apoptosis in cardiac myocytes. Involvement of the sphingolipid signaling cascade in cardiac cell death. J Clin Invest. 98:1996;2854-2865.